NuCana (NCNA) Stock Chart & Stock Price History $3.42 +0.11 (+3.26%) As of 03:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NuCana Stock Price Performance The NuCana (NCNA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.79%, with a year-to-date return of -98.56%. In the past month, the stock has decreased 67.75%, reflecting recent market activity. As of the latest close, NuCana traded at $3.31 with a market cap of $99 thousand and volume of 538,738 shares. Five years ago, the stock traded at a split-adjusted price of $27,500.00, representing a 99.99% decrease over that period. At the time, it had a market cap of $176.03 million and a volume of 46 shares. Receive NCNA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-8.36%1 Month Performance-67.75%3 Month Performance-56.62%Year-To-Date Performance-98.56%1 Year Performance-99.79%5 Year Performance-99.99% NCNA Stock Chart for Friday, August, 22, 2025 NCNA Chart by TradingView NuCana Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$3.11$3.31+6.43%$3.78$3.20538,738 shs$99,000.0008/20/2025$3.56$3.11-12.64%$3.47$3.05549,372 shs$93,000.0008/19/2025$3.87$3.56-8.01%$4.03$3.55346,785 shs$107,000.0008/18/2025$3.73$3.87+3.75%$4.03$3.75340,755 shs$116,000.0008/15/2025$4.15$3.73-10.12%$4.43$3.72618,093 shs$112,000.0008/14/2025$4.55$4.15-8.79%$4.52$4.12519,426 shs$125,000.0008/13/2025$4.71$4.55-3.40%$4.95$4.53469,881 shs$136,000.0008/12/2025$4.47$4.71+5.37%$5.70$4.621.18 million shs$28.64 million08/11/2025N/A$4.47$5.13$4.121.52 million shs$27.18 million08/07/2025$8.08$6.56-18.81%$8.06$6.50968,670 shs$199,000.00 Get the Latest News and Ratings for NCNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter. 08/06/2025$8.50$8.08-4.94%$8.60$7.82386,263 shs$246,000.0008/05/2025$9.14$8.50-7.00%$10.00$8.22444,876 shs$258,000.0008/04/2025$7.82$9.14+16.88%$9.40$8.30618,832 shs$278,000.0008/01/2025$8.58$7.82-8.86%$8.50$7.06606,420 shs$238,000.0007/31/2025$9.34$8.58-8.14%$9.36$8.00559,921 shs$261,000.0007/30/2025$10.00$9.34-6.60%$9.66$9.06613,890 shs$284,000.0007/29/2025$11.00$10.00-9.09%$10.60$9.041.12 million shs$304,000.0007/28/2025$11.92$11.00-7.72%$12.36$10.701.69 million shs$334,000.0007/25/2025$10.80$11.92+10.37%$12.40$10.402.50 million shs$362,000.0007/24/2025$10.52$10.80+2.66%$13.00$10.202.12 million shs$328,000.0007/23/2025$10.60$10.52-0.75%$10.92$10.12754,603 shs$320,000.0007/22/2025$10.20$10.60+3.92%$11.50$10.301.23 million shs$322,000.0007/21/2025$9.54$10.20+6.92%$11.00$10.061.73 million shs$310,000.00 Related Companies Genelux Stock Chart Connect Biopharma Stock Chart IO Biotech Stock Chart Protara Therapeutics Stock Chart Inhibikase Therapeutics Stock Chart OKYO Pharma Stock Chart Adagene Stock Chart Liminatus Pharma Stock Chart Scilex Stock Chart Tenaya Therapeutics Stock Chart Receive NCNA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NCNA) was last updated on 8/22/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuCana PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share NuCana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access